RapidAI Announces $25 Million in Series B Funding to Expand AI-Enhanced Cerebrovascular Imaging…
Founded in 2011, RapidAI makes the most-widely used advanced cerebrovascular imaging products for patient care, research, and clinical trials. This funding will support the continued advancement of the Rapid® platform and world-class!-->…